IMPACT OF OA

Osteoarthritis (OA) is a degenerative disease that affects more than 30 million Americans and accounts for more than $185 billion in annual expenditures.

Learn More

OUR PRODUCT

A non-opioid, extended-release, intra-articular injection that employs our proprietary microsphere technology to treat OA knee pain.

Read More

OUR SCIENCE

We are tireless in our pursuit of innovative science which holds the potential to transform the treatment of musculoskeletal conditions.

Learn More

OUR PIPELINE

Flexion’s strategy is to build a robust pipeline of locally administered therapies to address musculoskeletal conditions, with an initial focus on OA.

See the Pipeline

Join Our Team

Flexion Therapeutics prides itself on finding great talent, rewarding hard work and maintaining a culture that is unparalleled.

2019 BBJ Best Places to Work badge. . . The Boston Globe Top Places to Work 2018

Learn More

Events

Flexion Logo

December 11-14, 2019
Las Vegas, NV
Orthopaedic Summit 2019:
Evolving Techniques Annual Meeting

Visit Booths 118 and 213